Farnesoid X Receptor, through the Binding with Steroidogenic Factor 1-responsive Element, Inhibits Aromatase Expression in Tumor Leydig Cells-Reference-Cited by-同舟云学术

Farnesoid X Receptor, through the Binding with Steroidogenic Factor 1-responsive Element, Inhibits Aromatase Expression in Tumor Leydig Cells

Published:2010-02 Issue:8 Volume:285 Page:5581-5593
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Catalano Stefania,Malivindi Rocco,Giordano Cinzia,Gu Guowei,Panza Salvatore,Bonofiglio Daniela,Lanzino Marilena,Sisci Diego,Panno Maria Luisa,Andò Sebastiano

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference49 articles.

1. Identification of a nuclear receptor that is activated by farnesol metabolites

2. Identification of a Nuclear Receptor for Bile Acids

3. Bile Acids: Natural Ligands for an Orphan Nuclear Receptor

4. LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism

5. Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Bushen Huoxue recipe on serum metabolomics in polycystic ovary syndrome rats;Gynecological Endocrinology;2023-10-17

2. Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank;Metabolism;2023-01

3. Farnesoid X receptor functions in cervical cancer via the p14ARF-mouse double minute 2-p53 pathway;Molecular Biology Reports;2022-03-28

4. Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells;Cancers;2021-09-10

5. Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer;Molecular Biomedicine;2021-07-10